The Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia 5000, Australia.
ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia.
Cold Spring Harb Perspect Biol. 2018 Jun 1;10(6):a028514. doi: 10.1101/cshperspect.a028514.
The β common ([βc]/CD131) family of cytokines comprises granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3, and IL-5, all of which use βc as their key signaling receptor subunit. This is a prototypic signaling subunit-sharing cytokine family that has unveiled many biological paradigms and structural principles applicable to the IL-2, IL-4, and IL-6 receptor families, all of which also share one or more signaling subunits. Originally identified for their functions in the hematopoietic system, the βc cytokines are now known to be truly pleiotropic, impacting on multiple cell types, organs, and biological systems, and thereby controlling the balance between health and disease. This review will focus on the emerging biological roles for the βc cytokines, our progress toward understanding the mechanisms of receptor assembly and signaling, and the application of this knowledge to develop exciting new therapeutic approaches against human disease.
β 共用(βc/CD131)细胞因子家族包括粒细胞巨噬细胞集落刺激因子(GM-CSF)、白细胞介素(IL)-3 和 IL-5,它们都使用βc 作为其关键信号转导受体亚基。这是一个典型的信号转导亚基共享细胞因子家族,揭示了许多适用于 IL-2、IL-4 和 IL-6 受体家族的生物学范例和结构原则,这些家族也都共享一个或多个信号转导亚基。最初因其在造血系统中的功能而被识别,现在已知βc 细胞因子是真正的多效性的,影响多种细胞类型、器官和生物系统,从而控制健康与疾病之间的平衡。本综述将重点介绍βc 细胞因子的新兴生物学作用、我们在理解受体组装和信号转导机制方面的进展,以及将这些知识应用于开发针对人类疾病的令人兴奋的新治疗方法。